MedDataX Logo

Measures of Obesity and Co-Morbid Conditions in Maori

NCT ID: NCT00208598

Last Updated: 2005-09-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

220 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-01-31

Study Completion Date

2005-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It has been proposed that a higher cut off for BMI (body mass index) is to be used in Maori to define overweight and obesity. However, no one has assessed the prevalence of co-morbid conditions associated with BMI. It is well known that Maori are at greater risk of diabetes and cardiovascular disease compared to non-Maori and a delay in the identification of those who are overweight and obese may be detrimental for Maori. We will assess BMI, other measures of adiposity and prevalence of co-morbid conditions with a comparison with a similar matched non-Maori population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a body composition analysis study of people self-identifying Maori and non-Maori participants from both Dunedin and Invercargill. The study consists of a clinical visit for anthropometry and oral glucose tolerance test (OGTT), followed by a single Dexa Scan visit. Participants meeting all the inclusion criteria were invited to participate in the study.

Outcome will be determined by examining Dexa Scan data and surrogate clinical endpoints. The clinical endpoints include: anthropometric measurements, Dexa analysis, bioelectric impedance, and BP measurements, and the biochemical measures of: lipid profile, fasting insulin and glucose, liver functions and uric acid levels.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Body Composition

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Maori Body Composition DEXA Cardiovascular disease Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Self identify as Maori and non-Maori aged between 18-68 years
* Male and female
* Non-diabetic
* Resident of Dunedin and Invercargill

Exclusion Criteria

* The presence of diabetes, renal or liver failure, or any other medical condition which is unstable and for which they are currently having active treatment
Minimum Eligible Age

18 Years

Maximum Eligible Age

68 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Edgar National Centre for Diabetes Research

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jim I Mann, FRACP, PhD

Role: STUDY_DIRECTOR

Edgar National Centre for Diabetes Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Edgar National Centre for Diabetes Research

Dunedin, Otago, New Zealand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

New Zealand

Related Links

Access external resources that provide additional context or updates about the study.

http://www.otago.ac.nz/diabetes

Edgar National Centre for Diabetes Research, NZ website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ENCDR_3

Identifier Type: -

Identifier Source: org_study_id